Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Selective norepinephrine reuptake inhibitor (NRI) with 5HT1A partial agonism

or Stimulant

or Tryptamine

Use the filters below to narrow your results.

None (67) · Benzedrex (1) · Qelbree (1)

5-HT2A agonist (15) · Monoamine releasing agent (8) · Dopamine/norepinephrine reuptake inhibitor (5) · Cathinone analogue; monoamine reuptake inhibitor (2) · Dopamine and norepinephrine reuptake inhibitor (2) · Norepinephrine–dopamine reuptake inhibitor (2)

Other values:

None (68) · ADHD in children (6+), adolescents, and adults (FDA-approved 2021 for pediatric, 2022 for adult) (1)

None (68) · Pediatric 6-11: 100 mg PO daily, titrate weekly to max 400 mg. Adolescent 12-17: 200 mg, max 400 mg. Adult: 200 mg, max 600 mg. (1)

None (68) · 100 mg, 150 mg, 200 mg extended-release capsules (can be sprinkled on food) (1)

None (68) · 400 mg/d (pediatric); 600 mg/d (adult) (1)

None (68) · Oral (1)

None (68) · ADHD symptom improvement reported within 1-2 weeks (faster than atomoxetine which takes 4-6 weeks) (1)

None (68) · Daily dosing (1)

None (68) · ~7 hours (1)

None (68) · Adequate oral bioavailability with extended-release formulation (1)

None (68) · Limited data (1)

None (68) · Rx, '''not a controlled substance''' (no DEA scheduling) (1)

Showing below up to 70 results in range #1 to #70.

2

3

4

5

A

B

C

D

E

H

Hexedrone

I

Isopropylphenidate

M

N

P

R

RTI-111

T

V

Viloxazine

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"